野田 航介 業績集

英文業績(1998年から現在まで)

IF (impact factor): 2018年ISI Journal Citation Reportsより

 

本数

IF合計

一編あたり

First author

10 

37.140 

3.714 

Corresponding author

34

109.898

3.232

Second author

23

100.171

4.355

その他

105

443.947

4.228

英文全業績

172

693.004

4.030

   以下、Corresponding authorの論文の番号に印を付します

  1. Mitamura M, Noda K, Kase S, Hirooka K, Ishida S. Retinal hypoperfusion detected by wide-field optical coherence tomographic angiography in a case of retinal racemose hemangioma. Retin Cases Brief Rep. Epub ahead of print
  2. Hasegawa A, Noda K, Fujiya A, Hirooka K, Anzai T, Ishida S. Outer Retinal Abnormalities in a Patient with Danon Disease. Retin Cases Brief Rep. Epub ahead of print
  3. Hase K, Namba K, Wada H, Tsuji H, Maeda A, Murata T, Otsuka R, Iwata D, Kanda A, Noda K, Kitaichi N, Seino K, Ishida S. Macrophage-like iPS-derived suppressor cells reduce Th1-mediated immune response to a retinal antigen. Curr Eye Res. 2022; 46: 1908-1916
  4. Hirooka K, Saito M, Yamashita Y, Hashimoto Y, Terao N, Koizumi H, Noda K, Ishida S. Imbalanced Choroidal Circulation in Eyes with Asymmetric Dilated Vortex Vein. Jpn J Ophthalmol. 2022; 66: 14-18
  5. Kase S, Hasegawa A, Hirooka K, Endo H, Noda K, Ishida S. Laser speckle flowgraphy findings in a patient with radiation retinopathy. Int J Ophthalmol. 2022; 15: 172-174
  6. Noda T, Noda K, Hirooka K, Kase S, Ishida S. Subretinal fluid accumulation in a patient with polycythemia vera after receiving a prostaglandin I2 analogue treatment. Am J Ophthalmol Case Rep. inpress
  7. Fukutsu K, Murata M, Kikuchi K, Yoshida S, Noda K, Ishida S. ROCK1 mediates retinal glial cell migration promoted by acrolein. Front Med. 2021; 8: 717602
  8. Fukutsu K, Saito M, Noda K, Murata M, Kase S, Shiba R, Isogai N, Asano Y, Hanawa N, Dohke M, Kase M, Ishida S. A deep learning architecture for vascular area measurement in fundus images. Ophthalmology Science. 2021; 1: 100004
  9. Hase K, Kase S, Kanda A, Shinmei Y, Noda K, Ishida S. Expression of vascular endothelial growth factor-C in the trabecular meshwork of patients with neovascular glaucoma and primary open-angle glaucoma. J Clin Med. 2021; 10: 2977
  10. Hashimoto Y, Saito W, Kanaizumi S, Saito M, Noda K, Kanda A, Ishida S. Comparison of clinical characteristics in patients with acute zonal occult outer retinopathy according to anti-retinal antibody status. Graefes Arch Clin Exp Ophthalmol. 2021; 259: 2967-2976
  11. Hirano T, Toriyama Y, Takamura Y, Sugimoto M, Nagaoka T, Sugiura Y, Okamoto F, Saito M, Noda K, Yoshida S, Ishibazawa A, Sawada O, Murata T. Outcomes of a 2-year treat-and-extend regimen with aflibercept for diabetic macular edema. Sci Rep. 2021; 11: 4488
  12. Hirano T, Toriyama Y, Takamura Y, Sugimoto M, Nagaoka T, Sugiura Y, Okamoto F, Saito M, Noda K, Yoshida S, Ishibazawa A, Sawada O, Murata T. Treat-and-extend therapy with aflibercept for diabetic macular edema: a prospective clinical trial. Jpn J Ophthalmol. 2021; 65: 354-362
  13. Kase S, Noda K, Ishida S. Histological observation in pachyvessels in a patient with choroidal melanoma. Int J Ophthalmol. 2021; 14: 777-779
  14. Shinkai A, Saito W, Hashimoto Y, Saito M, Kase S, Noda K, Ishida S. Morphological features of macular telangiectasia type 2 in Japanese patients. Graefes Arch Clin Exp Ophthalmol. 2021; 259: 1179-1189
  15. Takamura Y, Kida T, Noma H, Inoue M, Yoshida S, Nagaoka T, Noda K, Yomada Y, Morioka M, Gozawa M, Matsumura T, Inatomi M. The Impact of Interval between Recurrence and Reinjection in Anti-VEGF Therapy for Diabetic Macular Edema in Pro Re Nata Regimen. J Clin Med. 2021; 10: 5738
  16. Ishizuka ET, Kanda A, Shinmei Y, Ohguchi T, Tagawa Y, Hase K, Yamamoto T, Noda K, Chin S, Ishida S. Receptor-Associated Prorenin System in the Trabecular Meshwork of Patients with Primary Open-Angle Glaucoma and Neovascular Glaucoma. J Clin Med. 2020; 9: E2336
  17. Kanda A, Hirose I, Noda K, Murata M, Ishida S. Glucocorticoid-transactivated TSC22D3 attenuates hypoxia- and diabetes-induced Müller glial galectin-1 expression via HIF-1α destabilization. J Cell Mol Med. 2020; 24: 4589-4599
  18. Kataoka K, Kase S, Noda K, Ishida S. Laser speckle flowgraphy findings in a patient with choroidal macrovessel. Ophthalmol Retina. 2020; 4: 1123-1124
  19. Kikuchi K, Dong Z, Shinmei Y, Murata M, Kanda A, Noda K, Harada T, Ishida S. Cytoprotective effect of astaxanthin in a model of normal intraocular pressure glaucoma. J Ophthalmol. 2020; 2020: 9539681
  20. Kikuchi K, Murata M, Noda K, Kase S, Tagawa Y, Kageyama Y, Shinohara M, Sasase T, Ishida S. Diabetic Cataract in Spontaneously Diabetic Torii Fatty Rats. J Diabetes Res. 2020; 2020: 3058547
  21. Liu Y, Kitaichi N, Wu D, Hase K, Satoh M, Iwata D, Namba K, Kanda A, Noda K, Itai A, Iwabuchi K, Ishida S. Attenuation of experimental autoimmune uveoretinitis in mice by IKKβ inhibitor IMD-0354. Biochem Biophys Res Commun. 2020; 525: 589-594
  22. Liu Y, Noda K, Murata M, Wu D, Kanda A, Ishida S. Blockade of Platelet-Derived Growth Factor Signaling Inhibits Choroidal Neovascularization and Subretinal Fibrosis in Mice. J Clin Med. 2020; 9: E2242
  23. Murata M, Noda K, Ishida S. Pathological role of unsaturated aldehyde acrolein in diabetic retinopathy. Front Immunol. 2020; 11: 589531
  24. Saito M, Noda K, Saito W, Hirooka K, Hashimoto Y, Ishida S. Increased choroidal blood flow and choroidal thickness in patients with hypertensive chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2020; 258: 233-240
  25. Takamura Y, Yamada Y, Noda K, Morioka M, Hashimoto Y, Gozawa M, Matsumura T, Inatani M. Characteristic distribution of microaneurysms and capillary dropouts in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2020; 258: 1625-1630
  26. Wu D, Kanda A, Liu Y, Noda K, Murata M, Ishida S. Involvement of Müller glial autoinduction of transforming growth factor-β in diabetic fibrovascular proliferation via glial-mesenchymal transition. Invest Ophthalmol Vis Sci. 2020; 61: 29
  27. Wu D, Noda K, Murata M, Liu Y, Kanda A, Ishida S. Regulation of Spermine Oxidase through Hypoxia-inducible Factor-1α Signaling in Retinal Glial Cells under Hypoxic Conditions. Invest Ophthalmol Vis Sci. 2020; 61: 52
  28. Hase K, Kanda A, Noda K, Ishida S. Increased plasma galectin-1 correlates with advanced glycation end products and interleukin-1β in patients with proliferative diabetic retinopathy. Int J Ophthalmol. 2019; 12: 692-694
  29. Hashimoto Y, Saito W, Hasegawa Y, Noda K, Ishida S. Involvement of inner choroidal layer in choroidal thinning during regression of multiple evanescent white dot syndrome. J Ophthalmol. 2019; 2019: 6816925
  30. Hashimoto Y, Saito W, Namba K, Mizuuchi K, Iwata D, Noda K, Kanda A, Ishida S. Comparison of clinical characteristics in patients with Vogt-Koyanagi-Harada disease with and without anti-retinal antibodies. Graefes Arch Clin Exp Ophthalmol. 2019; 257: 1751-1758
  31. Hirose I, Kanda A, Noda K, Ishida S. Glucocorticoid receptor inhibits Müller glial galectin-1 expression via DUSP1-dependent and -independent deactivation of AP-1 signalling. J Cell Mol Med. 2019; 23: 6785-6796
  32. Kanda A, Noda K, Hirose I, Ishida S. TGF-β-SNAIL axis induces Müller glial-mesenchymal transition in the pathogenesis of idiopathic epiretinal Sci Rep. 2019; 9: 673
  33. Liu Y, Kanda A, Wu D, Ishizuka ET, Kase S, Noda K, Ichihara A, Ishida S. Suppression of choroidal neovascularization and fibrosis by a novel RNAi therapeutic agent against (pro)renin receptor. Mol Ther Nucleic Acids. 2019; 17: 113-125
  34. Murata M, Noda K, Yoshida S, Saito M, Fujiya A, Kanda A, Ishida S. Unsaturated Aldehyde Acrolein Promotes Retinal Glial Cell Migration. Invest Ophthalmol Vis Sci. 2019; 60: 4425-4435
  35. Tagawa Y, Noda K, Ohguchi T, Tagawa Y, Ishida S, Kitaichi N. Corneal hyperalgesia in patients with short tear film break-up time dry eye. Ocul Surf. 2019; 17: 55-59
  36. Wu D, Kanda A, Liu Y, Kase S, Noda K,  Ishida S. Galectin-1 promotes choroidal neovascularization and subretinal fibrosis mediated via epithelial-mesenchymal transition. FASEB J. 2019; 33: 2498-2513
  37. Ando R, Saito W, Kanda A, Kase S, Fujinami K, Sugahara M, Nakamura Y, Eguchi S, Mori S, Noda K, Shinoda K, Ishida S. Clinical features of Japanese patients with anti-α-enolase antibody-positive autoimmune retinopathy: Novel subtype of multiple drusen. Am J Ophthalmol2018; 196: 181-196
  38. Kase S, Mori S, Noda K, Ishida S. Anterior proliferative vitreoretinopathy in a patient with Coats disease. Int J Ophthalmol. 2018; 11: 343-345
  39. Tanaka A, Saito W, Kase S, Ishijima K, Noda K, Ishida S. Role of the epipapillary membrane in maculopathy associated with cavitary optic disc anomalies: morphology, surgical outcomes, and histopathology. J Ophthalmol. 2018; 5680503
  40. Saito M, Noda K, Saito W, Ishida S. Relationship between choroidal blood flow velocity and choroidal thickness in patients with regression of acute central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2017; 7: 44266
  41. Yoshida S, Murata M, Noda K, Matsuda T, Saito M, Saito W, Kanda A, Ishida S. Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells. Jpn J Ophthalmol. 2018; 62: 256-264
  42. Dong Y, Kanda A, Noda K, Saito W, Ishida S. Pathologic roles of receptor-associated prorenin system in idiopathic epiretinal membrane. Sci Rep. 2017; 7: 44266
  43. Dong Y, Noda K, Murata M, Yoshida S, Saito W, Kanda A, Ishida S. Localization of Acrolein-lysine adduct in fibrovascular tissues of proliferative diabetic retinopathy. Curr Eye Res. 2017; 42: 111-117
  44. Hase K, Kanda A, Hirose I, Noda K, Ishida S. Systemic factors related to soluble (pro)renin receptor in plasma of patients with proliferative diabetic retinopathy. PLoS ONE.2017; 12: e0189696
  45. Hashimoto Y, Saito W, Saito M, Hasegawa Y, Takita A, Mori S, Noda K, Ishida S. Relationship between choroidal thickness and visual field impairment in acute zonal occult outer retinopathy. J Ophthalmol. 2017; 2017:2371032
  46. Kanda A, Dong Y, Noda K, Saito W, Ishida S. Advanced glycation endproducts link inflammatory cues to upregulation of galectin-1 in diabetic retinopathy. Sci Rep. 2017; 7: 16168
  47. Kanda A, Ishizuka ET, Shibata A, Matsumoto T, Toyofuku H, Noda K, Namba K, Ishida S. A novel single-strand RNAi therapeutic agent targeting (pro)renin receptor suppresses ocular inflammation. Mol Ther Nucleic Acids. 2017; 7: 116-126
  48. Kinoshita S, Ohguchi T, Noda K, Murata M, Yasueda S, Obata H, Matsunaga T, Fukushima T, Kanda A, Ishida S. Evaluation of the safety and tolerability of conjunctival ring for posterior segment of the eye. Curr Eye Res. 2017; 30: 1-6
  49. Matsuda T, Noda K, Murata M, Kawasaki A, Kanda A, Mashima Y, Ishida S.Vascular Adhesion Protein-1 Blockade Suppresses Ocular Inflammation after Retinal Laser Photocoagulation in Mice. Invest Ophthalmol Vis Sci. 2017; 58: 3254-3261
  50. Murata M, Noda K, Kawasaki A, Yoshida S, Dong Y, Saito M, Dong Z, Ando R, Mori S, Saito W, Kanda A, Ishida S. Soluble vascular adhesion protein-1 mediates spermine oxidation as semicarbazide-sensitive amine oxidase: possible role in proliferative diabetic retinopathy. Curr Eye Res. 2017; 42: 1674-1683
  51. Dong Y, Dong Z, Kase S, Ando R, Fukuhara J, Kinoshita S, Inafuku S, Tagawa Y, Ishizuka ET, Saito W, Murata M, Kanda A, Noda K, Ishida S. Phosphorylation of alphaB-crystallin in epiretinal membrane of human proliferative diabetic retinopathy. Int J Ophthalmol.  2016; 9: 1100-1105
  52. Dong Y, Kase S, Dong Z, Fukuhara J, Tagawa Y, Ishizuka ET, Murata M, Shinmei Y, Ohguchi T, Kanda A, Noda K, Ishida S. Regulation of vascular endothelial growth factor-C by tumor necrosis factor-α in the conjunctiva and pterygium. Int J Mol Med. 2016; 38: 545-550
  53. Dong Z, Shinmei Y, Dong Y, Inafuku S, Fukuhara J, Ando R, Kitaichi N, Kanda A, Tanaka K, Noda K, Harada T, Chin S, Ishida S. Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma. Heliyon. 2016; 2: e00191
  54. Hashimoto Y, Saito W, Saito M, Hasegawa Y, Mori S, Noda K, Ishida S. Relationship between choroidal thickness and visual impairment in multiple evanescent white dot syndrome. Acta Ophthalmol. 2016; 94: e804-e806
  55. Hirooka K, Saito W, Saito M, Hashimoto Y, Mori S, Noda K, Ishida S. Increased choroidal blood flow velocity with regression of acute posterior multifocal placoid pigment epitheliopathy. Jpn J Ophthalmol. 2016; 60: 172-178
  56. Kase S, Saito W, Mori S, Saito M, Ando R, Dong Z, Suzuki T, Noda K, Ishida S. Clinical and histological evaluation of large macular holes surgery using the inverted internal limiting membrane flap technique. Clin Ophthalmol. 2016; 11: 9–14
  57. Kinoshita S, Noda K, Saito W, Kanda A, Ishida S. Vitreous levels of vascular endothelial growth factor-B in proliferative diabetic retinopathy. Acta Ophthalmol. 2016; 94: e521-523
  58. Fujiya A, Noda K, Yoshida S, Saito W, Ishida S. Increased Vascular Endothelial Growth Factor Level in the Subretinal Fluid of Eye with Vasoproliferative Retinal Tumors. Retin Cases Brief Rep. 2015; 9: 154-156
  59. Hashimoto Y, Saito W, Saito M, Hirooka K, Mori S, Noda K, Ishida S. Decreased choroidal blood flow velocity in the pathogenesis of multiple evanescent white dot syndrome. Graefes Arch Clin Exp Ophthalmol. 2015; 253: 1457-64
  60. Hashimoto Y, Saito W, Fujiya A, Yoshizawa C, Hirooka K, Mori S, Noda K, Ishida S. Changes in inner and outer retinal layer thicknesses after vitrectomy for idiopathic macular hole: Implications for visual prognosis. PLoS One. 2015; 10: e0135925
  61. Hashimoto Y, Saito W, Saito M, Hirooka K, Mori S, Noda K, Ishida S. Increased choroidal blood flow velocity with regression of unilateral acute idiopathic maculopathy. Jpn J Ophthalmol. 2015; 59: 252-260
  62. Inafuku S, Noda K, Amano M, Nishimura S, Ishida S. Increase of sialylated N-glycans in eyes with neovascular glaucoma secondary to proliferative diabetic retinopathy. Curr Eye Res. 2015 Jul 15:1-4
  63. Inafuku S, Noda K, Amano M, Ohashi T, Yoshizawa C, Saito W, Kanda A, Nishimura S, Ishida S. Alteration of N-glycan profiles in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2015; 56: 5316-5322
  64. Kanda A, Noda K, Ishida S. ATP6AP2/(pro)renin receptor contributes to glucose metabolism via stabilizing the pyruvate dehydrogenase E1 ß subunit. J Biol Chem. 290:9690-9700, 2015
  65. Kanda A, Noda K, Saito W, Ishida S. Aflibercept traps galectin-1, an angiogenic factor associated with diabetic retinopathy. Sci Rep. 5: 17946, 2015
  66. Morooka S, Hoshina M, Kii I, Okabe T, Kojima H, Inoue N, Okuno Y, Denawa M, Yoshida S, Fukuhara J, Ninomiya K, Ikura T, Furuya T, Nagano T, Noda K, Ishida S, Hosoya T, Ito N, Yoshimura N, Hagiwara M. Identification of a dual Inhibitor of SRPK1 and CK2 that attenuates pathological angiogenesis of macular degeneration in mice. Mol Pharmacol. 2015; 88: 316-325
  67. Saito M, Saito W, Hirooka K, Hashimoto Y, Mori S, Noda K, Ishida S. Pulse waveform changes in macular choroidal hemodynamics with regression of acute central serous chorioretinopathy. Invest Ophthalmol Vis Sci.  2015; 56: 6515-6522
  68. Saito S, Saito W, Saito M, Hashimoto Y, Mori S, Noda K, Namba K, Ishida S. Acute zonal occult outer retinopathy in Japanese patients: Clinical features, visual function, and factors affecting visual function. PLoS One. 2015;10:e0125133
  69. Ando R, Noda K, Tomaru U, Kamoshita M, Ozawa Y, Notomi S, Hisatomi T, Noda M, Kanda A, Ishibashi T, Kasahara M, Ishida S. Decreased Proteasomal Activity Causes Photoreceptor Degeneration in Mice. Invest Ophthalmol Vis Sci. 2014; 55: 4682-4690
  70. Ando R, Noda K, Namba S, Saito W, Kanda A, Ishida S. Aqueous humor levels of placental growth factor in diabetic retinopathy. Acta Ophthalmol. 2014; 92: 245-6
  71. Dong Z, Iwata D, Kitaichi N, Takeuchi M, Sato M, Endo N, Iwabuchi K, Ando R, Fukuhara J, Kinoshita S, Lennikov A, Kitamura M, Mizuuchi K, Kanda A, Noda K, Namba K, Yamagishi S, Ohno S, Ishida S. Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde derived-advanced glycation end product formation. J Leukoc Biol. 2014; 96: 1077-1085
  72. Hashimoto Y, Saito W, Noda K, Ishida S. Acquired focal choroidal excavation associated with multiple evanescent white dot syndrome: observations at onset and a pathogenic hypothesis. BMC Ophthalmol. 2014, 14:135
  73. Hashimoto Y, Saito W, Saito M, Hirooka K, Fujiya A, Yoshizawa C, Noda K, Ishida S. Retinal outer layer thickness increases after vitrectomy for epiretinal membrane and visual improvement positively correlates with photoreceptor outer segment length. Graefes Arch Clin Exp Ophthalmol. 2014; 252: 219-226
  74. Hashimoto Y, Saito W, Saito M, Hirooka K, Yoshizawa C, Noda K, Ishida S. Retinal outer layer thickness increases with regression of multiple evanescent white dot syndrome and visual improvement positively correlates with photoreceptor outer segment length. Acta Ophthalmol. 2014; 92: 591-592
  75. Hirooka K, Saito W, Noda K, Ishida S. Enhanced-depth imaging optical coherence tomography and laser speckle flowgraphy in a patient with acute macular neuroretinopathy. Ocul Immunol Inflamm. 2014; 22: 485-489
  76. Inafuku S, Noda K, Amano M, Ohashi, Yoshizawa C, Saito W, Kanda A, Nishimura S, Ishida S. A comparison of N-glycan profiles in human plasma and vitreous fluid. Graefes Arch Clin Exp Ophthalmol. 2014; 252: 1235-1243
  77. Ishizuka ET, Kanda A, Kase S, Noda K, Ishida S. Involvement of the Receptor-Associated Prorenin System in the Pathogenesis of Human Conjunctival Lymphoma. Invest Ophthalmol Vis Sci. 2014; 56: 74-80
  78. Kinoshita S, Noda K, Tagawa Y, Inafuku S, Dong Y, Fukuhara J, Dong Z, Ando R, Kanda A, Ishida S. Genistein Attenuates Choroidal Neovascularization. J Nutr Biochem. 2014; 25: 1177-1182
  79. Kinoshita S, Kase S, Ando R, Dong Z, Fukuhara J, Dong Y, Takashina S, Noda K, Noda M, Kanda A, Ishida S. Expression of vascular endothelial growth factor in human ocular adnexal lymphoma. Invest Ophthalmol Vis Sci. 2014; 55: 3461-7
  80. Lennikov A, Kitaichi N, Noda K, Mizuuchi K, Ando R, Dong Z, Fukuhara J, Kinoshita S, Namba K, Ohno S, Ishida S. Amelioration of endotoxin-induced uveitis treated with the sea urchin pigment echinochrome in rats. Mol Vis.  2014; 20: 171-177
  81. Noda K, Nakao S, Zandi S, Sun D, Hayes KC, Hafezi-Moghadam A. Retinopathy in a novel model of metabolic syndrome and type 2 diabetes:  New insight on the inflammatory paradigm. FASEB J. 2014; 28: 2038-46
  82. Saito M, Saito W, Hashimoto Y, Yoshizawa C, Shinmei Y, Noda K, Ishida S. Correlation between decreased choroidal blood velocity and the pathogenesis of acute zonal occult outer retinopathy. Clin Experiment Ophthalmol.2014; 42: 139-50
  83. Yoshizawa C, Saito W, Noda K, Ishida S. Pars plana vitrectomy for a patient with macular schisis associated with peripapillary intrachoroidal cavitation. Ophthalmic Surg Lasers Imaging Retina. 2014; 45: 350-353
  84. Dong Z, Noda K, Kanda A, Fukuhara J, Ando R, Murata M, Saito W, Hagiwara M, Ishida S. Specific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization. Mol Vis. 2013; 19:536-543
  85. Dong Z, Kase S, Ando R, Fukuhara J, Kinoshita S, Dong Y, Takashina S, Kanda A, Noda M, Noda K, Ishida S. Expression of alphaB-crystallin and vascular endothelial growth factor in conjunctival squamous cell carcinoma. Anticancer Res. 2013; 33: 3745-3751
  86. Fukuhara J, Kase S, Ohashi T, Ando R, Dong Z, Noda K, Ohguchi T, Kanda A, Ishida S. Expression of vascular endothelial growth factor C in human pterygium. Histochem Cell Biol. 2013; 139: 381-389
  87. Fukuhara J, Noda K, Murata M, Namba S, Kinoshita S, Dong Z, Ando R, Lennikov A, Kanda A, Ishida S. Tissue kallikrein attenuates choroidal neovascularization via cleavage of vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 2013; 54: 274-279
  88. Hirooka K, Saito W, Noda K, Ishida S. A patient with acute macular neuroretinopathy and central retinal vein occlusion. Clin Ophthalmol. 2013; 7: 1447-1450
  89. Kanda A, Noda K, Saito W, Ishida S. Vitreous renin activity correlates with vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol. 2013; 97: 666-668
  90. Kanda A, Noda K, Yuki K, Ozawa Y, Furukawa T, Ichihara A, Ishida S. Atp6ap2/(pro)renin receptor interacts with Par3 as a cell polarity determinant required for laminar formation during retinal development in mice. J Neurosci. 2013; 33: 19341-19351
  91. Kase S, Rao NA, Yoshikawa H, Fukuhara J, Noda K, Kanda A, Ishida S. Expression of vascular endothelial growth factor in eyes with Coats disease. Invest Ophthalmol Vis Sci. 2013; 54: 57-62
  92. Lennikov A, Kitaichi N, Kase S, Noda K, Horie Y, Nakai A, Ohno S, Ishida S. Induction of heat shock protein 70 ameliorates ultraviolet-induced photokeratitis in mice. Int J Mol Sci. 2013; 14: 2175-2189
  93. Noda K, Ishida S. Role of chronic inflammation in diabetic retinopathy. Inflamm Regen. 2013; 33: 230-237
  94. Saito W, Kase S, Fujiya A, Dong Z, Noda K, Ishida S. Expression of vascular endothelial growth factor (VEGF) and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors. 2013; 33: 1959-1967
  95. Saito M, Saito W, Hashimoto Y, Yoshizawa C, Fujiya A, Noda K, Ishida S. Macular choroidal blood flow velocity decreases with regression of acute central serous chorioretinopathy. Br J Ophthalmol. 2013; 251: 1447-1449
  96. Takashina S, Saito W, Noda K, Katai M, Ishida S. Membrane tissue on the optic disc may cause macular schisis associated with a glaucomatous optic disc without optic disc pits. Clin Ophthalmol. 2013; 7: 883-887
  97. Yoshikawa N, Noda K, Ozawa Y, Mashima Y, Ishida S. Blockade for vascular adhesion protein-1 suppresses pathological neovascularization in oxygen-induced retinopathy. Acta Ophthalmol. 2013; 91: e409-e410 
  98. Yoshikawa N, Noda K, Shinoda H, Uchida A, Ozawa Y, Tsubota K, Mashima Y, Ishida S. Serum vascular adhesion protein-1 correlates with vascular endothelial growth factor in patients with type II diabetes. J Diabetes Complications. 2013; 27: 162-166
  99. Yoshizawa C, Saito W, Hirose S, Kitamei H, Noda K, Ishida S. Photodynamic therapy combined with intravitreal bevacizumab and sub-tenon triamcinolone acetonide injections for age-related macular degeneration. Jpn J Ophthalmol. 2013; 57: 68-73
  100. Dong Z, Kase S, Ando R, Fukuhara J, Saito W, Kanda A, Murata M, Noda K, Ishida S. AlphaB-crystallin expression in epiretinal membrane of human proliferative diabetic retinopathy. Retina. 2012; 32: 1190-1196
  101. Fukuhara J, Kase S, Noda K, Kanda A, Murata M, Noda M, Ando R, Dong Z, Ishida S. Immunolocalization of vascular adhesion protein-1 in human conjunctival tumors. Ophthalmic Res. 2012; 48: 33-37
  102. Hisatomi T, Nakao S, Murakami Y, Noda K, Nakazawa T, Notomi S, Connolly E, She H, Almulki L, Ito Y, Vavvas DG, Ishibashi T, Miller JW. The regulatory roles of apoptosis-inducing factor in the formation and regression processes of ocular neovascularization. Am J Pathol. 2012; 181: 53-61
  103. Horie Y, Meguro A, Kitaichi N, Lee E B, Kanda A, Noda K, Song Y W, Park K S, Namba K, Ota M, Inoko H, Mizuki N, Ishida S, Ohno S. Replication of a microsatellite genome-wide association study of Behcet disease in a Korean population. Rheumatology. 2012; 51: 983-986
  104. Kanda A, Noda K, Saito W, Ishida S. (Pro)renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy. Diabetologia. 2012; 55: 3104-3113
  105. Kanda A, Noda K, Oike Y, Ishida S. Angiopoietin-like protein 2 mediates endotoxin-induced acute inflammation in the eye. Lab Invest. 2012; 92: 1553-1563
  106. Lennikov A, Kitaichi N, Fukase R, Murata M, Noda K, Ando R, Ohguchi T, Kawakita T, Ohno S, Ishida S. Amelioration of ultraviolet-induced photokeratitis in mice treated with astaxanthin eye drops. Mol Vis. 2012; 18: 455-464
  107. Lennikov A, Kitaichi N, Noda K, Ando R, Dong Z, Fukuhara J, Kinoshita S, Namba K, Mizutani M, Fujikawa T, Itai A, Ohno S, Ishida S. Amelioration of endotoxin-induced uveitis treated with an IκB kinase β inhibitor in rats. Mol Vis. 2012; 18: 2586-2597
  108. Murata M, Noda K, Fukuhara J, Kanda A, Kase S, Saito W, Ozawa Y, Mochizuki S, Kimura S, Mashima Y, Okada Y, Ishida S. Soluble vascular adhesion protein-1 accumulates in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012; 53: 4055-62
  109. Noda K, Nakao S, Ishida S, Ishibashi T. Leukocyte adhesion molecules in diabetic retinopathy. J Ophthalmol. 2012; 2012: 279037
  110. Sasaki M, Yuki K, Kurihara T, Miyake S, Noda K, Kobayashi S, Ishida S, Tsubota K, Ozawa Y. Biological role of lutein in the light-induced retinal degeneration. J Nutr Biochem. 2012; 23: 423-429
  111. Yoshikawa N, Noda K, Ozawa Y, Tsubota K, Mashima Y, Ishida S. Blockade of vascular adhesion protein-1 attenuates choroidal neovascularization. Mol Vis. 2012; 18: 593-600
  112. Ando R, Kase S, Ohashi T, Dong Z, Fukuhara J, Kanda A, Murata M, Noda K, Kitaichi N, Ishida S. Tissue factor expression in human pterygium. Mol Vis. 2011; 17:63-69
  113. Hashimoto A, Hashimoto S, Ando R, Noda K, Ogawa E, Kotani H, Hirose M, Menju T, Morishige M, Manabe T, Toda Y, Ishida S, Sabe H. GEP100-Arf6-AMAP1-Cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis. PLoS ONE. 2011; 6: 1-11
  114. Hirasawa M, Noda K, Noda S, Suzuki M, Ozawa Y, Shinoda K, Inoue M, Ogawa Y, Tsubota K, Ishida S. Transcriptional factors associated with epithelial-mesenchymal transition in choroidal neovascularization. Mol Vis. 2011; 17: 1222-1230
  115. Kubota S, Ozawa Y, Kurihara T, Sasaki M, Yuki K, Miyake S, Noda K, Ishida S, Tsubota K. Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation. Invest Ophthalmol Vis Sci. 2011; 52: 9142-9148
  116. Kubota M, Shimmura S, Kubota S, Miyashita H, Kato N, Noda K, Ozawa Y, Usui T, Ishida S, Umezawa K, Kurihara T, Tsubota K. Hydrogen and N-acetyl-L-cysteine rescue oxidative stress-induced angiogenesis in a mouse corneal alkali-burn model. Invest Ophthalmol Vis Sc 2011; 52: 427-33
  117. Nakao S, Noda K, Zandi S, Sun D, Taher M, Schering A, Xie F, Mashima Y, Hafezi-Moghadam A. VAP-1-mediated M2 macrophage infiltration underlies IL-1β- but not VEGF-A-induced lymph- and angiogenesis. Am J Pathol. 2011;178:1913-1921
  118. Noda M, Noda K, Ideta S, Nakamura Y, Ishida S, Inoue M, Tsubota K. Repair of blowout orbital floor fracture by periosteal suturing. Clin Exp Ophthalmol. 2011; 39: 364-369
  119. Suzuki M, Ozawa Y, Kubota S, Hirasawa M, Miyake S, Noda K, Tsubota K, Kadonosono K, Ishida S. Neuroprotective response after photodynamic therapy: Role of vascular endothelial growth factor. J Neuroinflamm. 2011; 8: 176
  120. Yuki K, Ozawa Y, Yoshida T, Kurihara T, Hirasawa M, Ozeki N, Shiba D, Noda K, Ishida S, Tsubota K. Retinal ganglion cell loss in superoxide dismutase 1-deficiency. Invest Ophthalmol Vis Sci. 2011; 52: 4143-4150
  121. Almulki L, Noda K, Nakao S, Hisatomi T, Thomas KL, Hafezi-Moghadam A.Localization of vascular adhesion protein-1 (VAP-1) in the human eye. Exp EyeRes. 2010; 90: 26-32
  122. Kubota S, Kurihara T, Ebinuma M, Kubota M, Yuki K, Sasaki M, Noda K, Ozawa Y, Oike Y, Ishida S, Tsubota K. Resveratrol prevents light-induced retinal degeneration via suppressing activator protein-1 activation. Am J Pathol.  2010; 177: 1725-31
  123. Kurihara T, Kubota Y, Ozawa Y, Takubo K, Noda K, Simon MC, Johnson RS, Suematsu M, Tsubota K, Ishida S, Goda N, Suda T, Okano H. Von Hippel-Lindau protein regulates transition from fetal to adult circulatory system in retina. Development. 2010; 137: 1563-71
  124. Nakao S, Maruyama S, Souska Z, Mark M, Mahdi T, Noda K, Nusayr E, Doetschman T, Hafezi-Moghadam A. Lymphangiogenesis and angiogenesis: concurrence and/or dependence? Studies in inbred mouse strains. FASEB J. 2010; 24: 504-13
  125. Noda K, Melhorn M, Zandi S, Frimmel S, Tayyari F, Nakao S, Hisatomi T, Almulki L, Pronczuk A, Hayes KC, Hafezi-Moghadam A. An animal model of spontaneous metabolic syndrome: Nile grass rat. FASEB J. 2010; 24: 2443-53
  126. Sasaki M, OzawaY, Kurihara T, Kubota S, Yuki K, Noda K, Kobayashi S, Ishida S, Tsubota K. Neurodegenerative influence of oxidative stressin the retina of diabetic mice. Diabetologia. 2010; 53: 971-9
  127. Suzuki M, Noda K, Kubota S, Hirasawa M, Ozawa Y, Tsubota K, Mizuki N, Ishida S. Eicosapentaenoic acid suppresses ocular inflammation in endotoxin-induced uveitis. Mol Vis. 2010; 16: 1382–88
  128. Tomita Y, Noda K, Shinoda H, Ozawa Y, Tsubota K, Ishida S. Secondary macular hole formation with presumed evulsion of foveal hard exudates in a patient with diabetic retinopathy. Jpn J Ophthalmol. 2010; 54: 366-8
  129. Kurihara T, Omoto M, Noda K, Ebinuma M, Kubota S, Koizumi H, Yoshida S, Ozawa Y, Shimmura S, Ishida S, Tsubota K. Retinal phototoxicity in a novel murine model of intraocular lens implantation. Mol Vis. 2009; 15: 2751-61
  130. Almulki L, Noda K, Amini R, Schering A, Garland RC, Nakao S, Nakazawa T, Hisatomi T, Thomas KL, Masli S, Hafezi-Moghadam A. Surprising up-regulation of P-selectin glycoprotein ligand-1 (PSGL-1) in endotoxin-induced uveitis. FASEB J. 2009; 23: 929-39
  131. Castillo N, Zandi S, Nakao S, Ito Y, Noda K, She H, Ahmed M, Frimmel S,Ablonczy S, Hafezi-Moghadam A. Atrial Natriuretic Peptide Reduces Vascular Leakage and Choroidal Neovascularization. Am J Pathol. 2009; 175: 2343-50
  132. Hirasawa M, Noda K, Shinoda H, Ozawa Y, Tsubota K, Ishida S. Secondary macular hole associated with central retinal vein occlusion treated with corticosteroid injection. Jpn J Ophthalmol. 2009; 53: 279-81
  133. Kubota S, Kurihara T, Mochimaru H, Satofuka S, Noda K, Ozawa Y, Oike Y, Ishida S, Tsubota K. Resveratrol prevents ocular inflammation in endotoxin-induced uveitis via inhibiting oxidative damage and nuclear factor-{kappa}B activation. Invest Ophthalmol Vis Sci. 2009; 50: 3512-3519
  134. Kurihara T, Suzuki K, Noda K, Kawamura R, Nagai N, Shinoda H, Shinoda K, Tsubota K, Ishida S, Inoue M. New retractor capable of aspirating fluids during scleral buckling surgery. Retina. 2009; 29: 1542-4
  135. Mochimaru H, Takahashi E, Tsukamoto N, Miyazaki J, Yaguchi T, Koto T, Kurihara T, Noda K, Ozawa Y, Ishimoto T, Kawakami Y, Tanihara H, Saya H, Ishida S, Tsubota K. Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization. Invest Ophthalmol Vis Sci. 2009; 50: 4410-4415
  136. Noda K, Nakao S, Zandi S, Engelstädter V, Mashima Y, Hafezi-Moghadam A. Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes. Exp Eye Res. 2009; 89: 774-81
  137. Satofuka S, Ichihara A, Nagai N, Noda K, Ozawa Y, Fukamizu A, Tsubota K, Itoh H, Oike Y, Ishida S. (Pro) renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation. Diabetes. 2009; 58: 1625-33
  138. Sasaki M, Ozawa Y, Kurihara T, Noda K, Imamura Y, Kobayashi S, Ishida S, Tsubota K. Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Invest Ophthalmol Vis Sci. 2009; 50: 1433-9
  139. Hashizume K, Hirasawa M, Imamura Y, Noda S, Shimizu T, Shinoda K, Kurihara T, Noda K, Ozawa Y, Ishida S, Miyake Y, Shirasawa T, Tsubota K. Retinal dysfunction and progressive retinal cell death in SOD1-deficient mice. Am J Pathol. 2008; 172: 325-31
  140. Hisatomi T, Nakazawa T, Noda K, Almulki L, Miyahara S, Nakao S, Ito Y, She H, Kohno R, Michaud N, Ishibashi T, Hafezi-Moghadam A, Badley AD, Kroemer G, Miller JW. HIV protease inhibitors provide neuroprotection through inhibition of mitochondrial apoptosis in mice. J Clin Invest. 2008; 118: 2025-38
  141. Noda K, She H, Nakazawa T, Hisatomi T, Nakao S, Almulki L, Zandi S, Miyahara S, Ito Y, Thomas KL, Garland RC, Miller JW, Gragoudas ES, Mashima Y, Hafezi-Moghadam A. Vascular adhesion protein-1 blockade suppresses choroidal neovascularization. FASEB J. 2008; 22: 2928-35
  142. Kurihara T, Ozawa Y, Nagai N, Shinoda K, Noda K, Imamura Y, Tsubota K, Okano H, Oike Y, Ishida S. Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes. 2008; 57: 2191-8
  143. Miyahara S, Almulki L, Noda K, Nakazawa T, Hisatomi T, Nakao S, Thomas KL, Schering A, Zandi S, Frimmel S, Tayyari F, Garland RC, Miller JW, Gragoudas ES, Masli S, Hafezi-Moghadam A. In vivo imaging of endothelial injury in choriocapillaris during endotoxin-induced uveitis. FASEB J. 2008; 22: 1973-80
  144. Noda K, Miyahara S, Nakazawa T, Almulki L, Nakao S, Hisatomi T, She H, Thomas KL, Garland RC, Miller JW, Gragoudas ES, Kawai Y, Mashima Y, Hafezi-Moghadam A. Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis. FASEB J. 2008; 22: 1094-1103
  145. Satofuka S, Ichihara A, Nagai N, Noda K, Ozawa Y, Fukamizu A, Tsubota K, Itoh H, Oike Y, Ishida S. (Pro) renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system. Am J Pathol. 2008; 173: 1911-1918
  146. She H, Nakazawa T, Matsubara A, Connolly E, Hisatomi T, Noda K, Kim IK, Gragoudas ES, Miller JW. Dexamethasone reduces photoreceptor damage caused by photodynamic therapy in a rat model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2008; 49: 5008-5014
  147. Skondra D, Noda K, Almulki L, Tayyari F, Frimmel S, Nakazawa T, Kim IK, Zandi S, Thomas KL, Miller JW, Gragoudas ES, Hafezi-Moghadam A. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown. Invest Ophthalmol Vis Sci. 2008; 49: 726-731
  148. Hafezi-Moghadam A, Noda K, Almulki L, Iliaki EF, Poulaki V, Thomas KL, Nakazawa T, Hisatomi T, Miller JW, Gragoudas ES. VLA-4 blockade suppresses endotoxin-induced uveitis: in vivo evidence for functional integrin up-regulation. FASEB J. 2007; 21: 464-474
  149. Hisatomi T, Sonoda KH, Ishikawa F, Qiao H, Nakamura T, Fukata M, Nakazawa T, Noda K, Miyahara S, Harada M, Kinoshita S, Hafezi-Moghadam A, Ishibashi T, Miller JW. Identification of resident and inflammatory bone marrow derived cells in the sclera by bone marrow and hematopoietic stem cell transplantation. Br J Ophthalmol. 2007; 91: 520-526
  150. Kawamura R, Noda K, Negishi K, Shinoda K, Ishida S, Inoue M, Tsubota K. Intraoperative dehiscence of laser subepithelial keratomileusis (LASEK) flap during retinal detachment surgery. Acta Ophthalmol Scand. 2007; 85: 459
  151. Koto T, Nagai N, Mochimaru H, Kurihara T, Izumi-Nagai K, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Oike Y, Ishida S. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice. Invest Ophthalmol Vis Sci. 2007; 48: 4328-4334
  152. Matsubara A, Nakazawa T, Noda K, She H, Connolly E, Young TA, Ogura Y, Gragoudas ES, Miller JW. Photodynamic therapy induces caspase-dependent apoptosis in rat CNV model. Invest Ophthalmol Vis Sci. 2007; 48: 4741-4747
  153. Nagai N, Ishida S, Shinoda K, Imamura Y, Noda K, Inoue M. Surgical effects and complications of indocyanine green-assisted internal limiting membrane peeling for idiopathic macular hole. Acta Ophthalmol Scand. 2007; 85: 883-889
  154. Nagai N, Oike Y, Izumi-Nagai K, Koto T, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Ishida S. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin. Invest Ophthalmol Vis Sci. 2007; 48: 2321-6
  155. Nakao S, Hata Y, Miura M, Noda K, Kimura YN, Kawahara S, Kita T, Hisatomi T, Nakazawa T, Jin Y, Dana MR, Kuwano M, Ono M, Ishibashi T, Hafezi-Moghadam A. Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis. Am J Pathol. 2007; 171: 1058-1065
  156. Nakazawa T, Hisatomi T, Nakazawa C, Noda K, Maruyama K, She H, Matsubara A, Miyahara S, Nakao S, Yin Y, Benowitz L, Hafezi-Moghadam A, Miller JW. From the cover: Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis. Proc Natl Acad Sci U S A. 2007; 104: 2425-2430
  157. Satofuka S, Ichihara A, Nagai N, Koto T, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Itoh H, Oike Y, Ishida S. Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization. Invest Ophthalmol Vis Sci. 2007; 48: 422-429
  158. Nagai N, Oike Y, Izumi-Nagai K, Urano T, Kubota Y, Noda K, Ozawa Y, Inoue M, Tsubota K, Suda T, Ishida S. Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization. Arterioscler Thromb Vasc Biol. 2006; 26: 2252-9
  159. Nakazawa T, Matsubara A, Noda K, Hisatomi T, She H, Skondra D, Miyahara S, Sobrin L, Thomas KL, Chen DF, Grosskreutz CL, Hafezi-Moghadam A, Miller JW. Characterization of cytokine responses to retinal detachment in rats. Mol Vis. 2006; 12: 867-78
  160. Nakazawa T, Nakazawa C, Matsubara A, Noda K, Hisatomi T, She H, Michaud N, Hafezi-Moghadam A, Miller JW, Benowitz LI. Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci. 2006; 26: 12633-41
  161. Satofuka S, Ichihara A, Nagai N, Yamashiro K, Koto T, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Suzuki F, Oike Y, Ishida S. Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest Ophthalmol Vis Sci. 2006; 47: 2686-92
  162. Kurihara T, Noda K, Ishida S, Inoue M. Pars plana vitrectomy with internal limiting membrane removal for macular hole associated with proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2005; 243: 724-726
  163. Nagai N, Noda K, Urano T, Kubota Y, Shinoda H, Koto T, Shinoda K, Inoue M, Shiomi T, Ikeda E, Tsubota K, Suda T, Oike Y, Ishida S. Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci. 2005; 46: 1078-1084
  164. Nagai N, Oike Y, Noda K, Urano T, Kubota Y, Ozawa Y, Shinoda H, Koto T, Shinoda K, Inoue M, Tsubota K, Yamashiro K, Suda T, Ishida S. Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci. 2005; 46: 2925-31
  165. Noda K, Ishida S, Shinoda H, Koto T, Aoki T, Tsubota K, Oguchi Y, Okada Y, Ikeda E. Hypoxia induces the expression of membrane-type 1 matrix metalloproteinase in retinal glial cells. Invest Ophthalmol Vis Sci. 2005; 46: 3817-24
  166. Inoue M, Yamazaki K, Shinoda K, Ishida S, Shinoda H, Noda K, Oguchi Y. A clinicopathologic case report on macular hole associated with von Hippel-Lindau disease: a novel ultrastructural finding of wormlike, wavy tangles of filaments. Graefes Arch Clin Exp Ophthalmol. 2004; 242: 881-886
  167. Inoue M, Noda K, Ishida S, Yamaguchi T, Nagai N, Shinoda K, Shinoda H, Oguchi Y. Successful treatment of subfoveal choroidal neovascularization associated with combined hamartoma of the retina and retinal pigment epithelium. Am J Ophthalmol. 2004; 138: 155-156
  168. Inoue M, Noda K, Ishida S, Nagai N, Imamura Y, Oguchi Y. Intraoperative breakage of a 25-gauge vitreous cutter. Am J Ophthalmol. 2004; 138: 867-9
  169. Inoue M, Shinoda K, Ishida S, Shinoda H, Nagai N, Noda K, Oguchi Y. Treatment of retinal detachment after macular translocation with scleral infolding: preservation of macular translocation. Retina. 2004; 24: 962-4
  170. Noda K, Ishida S, Inoue M, Obata K, Oguchi Y, Okada Y, Ikeda E. Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2003; 44: 2163-70
  171. Mashima Y, Nakamura Y, Noda K, Konishi M, Yamada M, Kudoh J, Shimizu N. A novel mutation at codon 124 (R124L) in the BIGH3 gene is associated with a superficial variant of granular corneal dystrophy. Arch Ophthalmol. 1999; 117: 90-3
  172. Noda K, Mashima Y, Nakamura Y, Tanaka Y. Blepharophimosis-ptosis -epicanthus inversus syndrome associated with interstitial deletion of chromosome 3q21-23. J Pediatr Ophthalmol Strabismus. 1998; 35: 242-3